Dongqing Zuo

Dongqing Zuo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Micromachines
Verified
Journal Article
Open access
PDF file
SHshandeng / Huang
shandeng / Huang
YGYinghua Gao
Yinghua Gao
YLYu lv
Yu lv
YWYun Wang
Yun Wang
YCYinghao Cao
Yinghao Cao
YHYingqi Hua
Yingqi Hua
Natural biological lumens in the human body, such as blood vessels and the gastrointestinal tract, are important to the delivery of materials. Depending on the anatomic features of these biological lumens, the invention of nano/micromotors could automatically locomote targeted sites for disease treatment and diagnosis. These nano/micromotors are designed to utilize chemical, physical, or even hybrid power in self-propulsion or propulsion by external forces. In this review, the research progress of nano/micromotors is summarized with regard to treatment and diagnosis in different biological lumens. Challenges to the development of nano/micromotors more suitable for specific biological lumens are discussed, and the overlooked biological lumens are indicated for further studies.

16 October 2025 in Journal of Orthopaedic Translation
Verified
Journal Article
Open access
BYBinghui Yang
Binghui Yang
HWHaoyu Wang
Haoyu Wang
YTYining Tao
Yining Tao
XYXiyu Yang
Xiyu Yang
HMhaoran mu
haoran mu
WSWei Sun
Wei Sun
Osteosarcoma (OS) is a highly aggressive primary bone tumor with poor outcomes, particularly in metastatic or recurrent cases. Methionine metabolism and histone methylation, such as H3K27me3, play crucial roles in OS progression. We analyzed single-cell RNA sequencing (scRNA-seq) data to identify histone methylation and related pathways associated with malignant proliferation OS cells. A high-throughput compound screen was performed to evaluate potential metabolic and epigenetic targets. In vitro and in vivo experiments were conducted to assess the therapeutic potential of MAT2A inhibition, methionine restriction, and EZH2 inhibition. MAT2A inhibition or methionine restriction reduced H3K27me3 levels, induced DNA damage, and suppressed OS cell growth. Combining MAT2A and EZH2 inhibitors demonstrated synergistic effects in reducing H3K27me3 levels, enhancing DNA damage, and inhibiting OS growth both in vitro and in vivo. The combination of MAT2A and EZH2 inhibition significantly reduces intracellular H3K27me3 levels by depleting S-adenosylmethionine (SAM) and inhibiting synthetic enzyme activity, thereby inducing DNA damage in osteosarcoma (OS). Methionine-restricted diet combined with EZH2 inhibition effectively suppresses osteosarcoma growth in vivo. This study highlights the potential of integrating metabolic and epigenetic interventions in OS therapy. Our findings might present a promising therapeutic strategy for chemotherapy-resistance OS.

23 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
DZDongqing Zuo
Dongqing Zuo
MYMingyang Yu
Mingyang Yu
HMHaoran Mu
Haoran Mu
MSMengxiong Sun
Mengxiong Sun
JSJiakang Shen
Jiakang Shen
ZCZhengdong Cai
Zhengdong Cai
Background: To explore the feasibility and short-term effect of posterior K-L (Kocher Langenbeek) approach in treating pelvic acetabular tumors involving ishium, inferior ramus of pubis. Methods: We retrospectively reviewed patients with acetabular tumors involving ishium, inferior ramus of pubis underwent surgery in Shanghai General Hospital from January 2016 to June 2020 with modified K-L approach, including 8 women and 12 men, patients aged from 19-76 years, including 6 chondrosarcomas, 6 osteosarcomas, 3 metastatic pelvic tumors, 2 epithelioid sarcomas, 3 giant cell tumor of bone. 20 patients were defined as pelvic Ennecking zone II + pelvic zone III involvement. All patients were followed up regularly in clinic, operation time, intraoperative bleeding, methods of reconstruction, duration of hospitalization, perioperative complications were recorded, and MSTS functional score was used to evaluate the patients' functional status.Results: All patients were followed up regularly in clinic with a mean 32 months (20-48 months). No patient died in the perioperative period, the average intraoperative bleeding was 1250 ml (800-2400 ml) in 10 patients, the mean operation duration was 2.6 hours (2-3.5 hours), no wound infection and delayed healing, the average duration of hospital stay was 12 days (10-16 days), the main complications during the follow-up included nervus cutaneus femoris posterior paralysis, 2 tumor recurrence, MSTS score was 22.5 points. 4 patients died during follow-up. Conclusions: The posterior K-L approach can be employed to effectively resect and reconstruction pelvic acetabular tumors invoving ishium, inferior ramus of pubis and reconstruct them properly. It is mainly suitable for malignant pelvic tumors involving the pelvic III and II + III regions. It also can often be available for biological reconstruction by using the acetabulum tantalum metal block, acetabulum reinforcing ring or autograft femur head. It is of highly safety and few perioperative complications, which is worth popularizing.

13 July 2021 in Research Square
Verified
Preprint
Open access
PDF file
MMMao Min
Mao Min
LZLei Zhou
Lei Zhou
XMXinglong Ma
Xinglong Ma
MYMengkai Yang
Mengkai Yang
GWGangyang Wang
Gangyang Wang
ZCZhengdong Cai
Zhengdong Cai
Background: Osteosarcoma (OS) is the most common malignant bone cancer. Recently, more studies have shown that TPX2, a potential oncogene considered to be an important prognostic biomarker, is widely expressed in various tumors. However, until now, little is known about the impacts of TPX2 on the pathogenesis of OS.Methods: TPX2 expression of in OS cells and tissues was detected by Western blot and immunohistochemical analyses. Various assays were used to analyze OS cell proliferation and metastasis in vitro and in vivo. The effect of TPX2 on the expression of E2F1 and proteins encoded by E2F1-regulated genes was evaluated by Western blotting. Coimmunoprecipitation, immunofluorescence and in vitro ubiquitination assays were employed to explore the molecular mechanisms underlying the effect of TPX2 on stabilizing E2F1 and maintaining E2F1 signaling.Results: TPX2 is overexpressed in OS and is significantly correlated with the malignant progression of OS. TPX2 probably plays a critical role in the proliferation and metastasis of OS cells in vitro. Furthermore, TPX2 regulates E2F1 signaling by affecting the stability of E2F1, thereby affecting the proliferation and metastasis of OS cells. In addition, PSMD14 impacts the degradation and regulates the stability of E2F1. Most importantly, TPX2 regulates the interaction of E2F1 and PSMD14 to influence E2F1 degradation.Conclusions: Our research not only identifies TPX2 as a promising therapeutic target in cancer but also illuminates its underlying molecular mechanism. We showed that TPX2 promotes the malignant progression of OS by regulating E2F1 signaling.